Indefinite Delivery Contract SPE2DB20D9331

This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The IDC, valued at up to $499,999,999, allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military health facilities worldwide.

Through this contract vehicle and related prime vendor agreements, DMS Pharmaceutical Group provides both routine and critical medications to the Department of Defense (DoD) and Department of Veterans Affairs (VA), solidifying its position as a crucial supplier in the federal pharmaceutical supply chain. The delivery orders awarded under this IDC cover a diverse array of pharmaceutical products, such as Velcade, Trikafta, Nucala, Botox, Xolair, Eylea, Entyvio, Exparel, and other specialty and common drugs. The contract has no set-aside designations, but leverages DMS Pharmaceutical Group's status as a woman-owned small business to secure direct awards from the DLA's Medical Supply Chain division.